Biostem (BSEM) traded down -3.9 % during a 24 hours period ending at 10:52 AM Central Europe on Wednesday 28th. One Biostem stock can currently be bought for about USD 1.48 on popular exchanges. Current supply of Biostem stocks is 18.7 mn. Biostem has a current market capitalization of USD 28.2 mn and approximately USD 274.8 k worth of Biostem was traded on exchanges in the last 24 hours. Since last month end, Biostem has traded -63.46 % down. Simple moving average of last 200 days is at USD 4.25. The highest price of past 52 weeks was recorded at USD 8.4 on 01/28/2026. 52 weeks low was at USD 1.4 on 10/26/2026.

Here is how related stocks have performed in the past 24 hours:

  • Teads (TEAD) traded up 1.46 % and now trades at USD 0.35. Current market capitalisation for Teads is USD 32.8 mn.

  • Royalty Management C (RMCO) traded flat 0 % and now trades at USD 2.21. Royalty Management C has a market capitalisation of USD 33.5 mn.

  • Birchtech (BCHT) traded up 1.61 % and now trades at USD 1.26. Current market capitalisation for Birchtech is USD 32.6 mn.

  • Qt Imaging (QTI) traded down -0.87 % and now trades at USD 2.28. Current market capitalisation for Qt Imaging is USD 33.4 mn. Evrima Plc has announced a convertible loan facility with Quatro Tree Investments, aiming to support the acquisition and recapitalisation of an operating fluorspar mine in Andalusia, Spain. The loan, initially advanced at €150,000, may be increased up to a total of €2 million and can be converted into up to ten per cent of the investor’s share capital. Proceeds will finance working‑capital support, debt acquisition and staged purchase payments linked to regulatory milestones. The deal is part of a broader strategy to invest in critical mineral assets, with fluorspar identified as a key material for the EU’s energy transition. Evrima will conduct further due diligence and secure additional financing as needed. The transaction reflects the company’s focus on leveraging its investment expertise to unlock value in established mining operations.

  • Interpace Biosciences (IDXG) traded flat 0 % and now trades at USD 5.5. Interpace Biosciences has a market capitalisation of USD 32.5 mn.

About Biostem

BioStem Technologies, Inc. is a regenerative medicine company that specializes in the stem cell industry for treating a variety of rare and common degenerative diseases. The company has its main operations in Pompano Beach, a health care sector located in the United States. They are also publicly traded on the Other-OTC stock exchange. You can learn more about their work and offerings by visiting their website at www.biostemtech.com .